These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32425506)

  • 1. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anisodamine inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in rhabdomyolysis-induced acute kidney injury.
    Yuan X; Zheng Y; Chen C; Wang C
    Apoptosis; 2017 Dec; 22(12):1524-1531. PubMed ID: 28918467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
    Saber S; Ghanim AMH; El-Ahwany E; El-Kader EMA
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):331-343. PubMed ID: 31989218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis.
    Zhang Y; Yang H; Sun M; He T; Liu Y; Yang X; Shi X; Liu X
    Pharmacol Rep; 2020 Oct; 72(5):1370-1382. PubMed ID: 32301055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.
    Xiao MY; Pei WJ; Li S; Li FF; Xie P; Luo HT; Hyun Yoo H; Piao XL
    Bioorg Chem; 2024 Sep; 150():107539. PubMed ID: 38861912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
    Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12368-12379. PubMed ID: 33336757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.
    Cao B; Chen XP; Zhu P; Ding L; Guan J; Shi ZL
    World J Gastroenterol; 2008 Nov; 14(44):6802-7. PubMed ID: 19058305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma
    Li X; Li X; Chen L; Deng Y; Zheng Z; Ming Y
    Anticancer Agents Med Chem; 2024; 24(10):764-772. PubMed ID: 38465429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3.
    Shen Z; Zhou H; Li A; Wu T; Ji X; Guo L; Zhu X; Zhang D; He X
    Aging (Albany NY); 2021 Sep; 13(18):22120-22133. PubMed ID: 34546972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword.
    Tang YL; Tao Y; Zhu L; Shen JL; Cheng H
    Int Immunopharmacol; 2023 May; 118():110107. PubMed ID: 37028274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
    Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
    Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells.
    Wei Q; Zhu R; Zhu J; Zhao R; Li M
    Oncol Res; 2019 Jul; 27(7):827-834. PubMed ID: 30940293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
    Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
    Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
    Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
    Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
    Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
    Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.